Core Insights - Mom's Garden showcased its "任我行" bone health series and "百草园" gut health products at the 8th China International Import Expo, gaining attention from major media outlets like CCTV and Xinhua [1][3] Group 1: Product Validation and Research - Mom's Garden has established a three-tier validation system: "Product Evidence - Sensory Verification - Clinical Evidence," focusing on Norwegian salmon bone calcium and citric acid calcium as core ingredients [3] - The brand collaborates with Fudan University Zhongshan Hospital to conduct clinical research aimed at evaluating the actual effects of salmon bone calcium on bone health [3] - During the expo, Mom's Garden announced the establishment of a Bone Health Research Institute to further expand partnerships with top medical and testing institutions in China [3] Group 2: Industry Trends and Competitive Landscape - Industry observers note that Mom's Garden's evidence-based approach is shifting competition from "price wars" and "marketing wars" back to "quality wars" and "effectiveness wars" [4] - The brand's comprehensive scientific system, from raw material safety to clinical validation, aligns with the principles of evidence-based medicine and provides a valuable case for cross-border collaboration and localized innovation in the health sector [4] - The introduction of the "Evidence Pyramid" model by Mom's Garden aims to transform calcium supplementation behavior from "experience-based" to "evidence-based," offering a reference path for the scientific development of the bone health industry in China [3][4]

Core Insights - The 10th China Special Food Conference highlighted the scientific achievements of Mead Johnson's children's nutrition brand, Xueyouli, particularly its positive impact on children's bone health through its formula containing colostrum alkaline protein and folic acid [1][2] - The research emphasizes the importance of scientific evidence in validating product efficacy and addressing parents' rational needs in children's nutrition [1][2] - Mead Johnson's commitment to scientific research and innovation is underscored by its 120-year history and its dual strategy focusing on both infant and children's adult nutrition [2][3] Group 1 - The study presented at the conference indicates that the combination of colostrum alkaline protein and folic acid in milk powder can activate the GH-IGF-1 axis, supporting linear bone growth and bone mass accumulation in children [2] - The findings suggest that the enhanced nutritional formula not only promotes height growth but also reduces the risk of obesity during puberty and potential long-term metabolic disorders [2] - Mead Johnson's senior vice president emphasized the brand's ability to adapt to consumer needs and its focus on breast milk as the gold standard for research, driving formula innovation through scientific evidence [2][3] Group 2 - The release of this research expands Mead Johnson's scientific evidence into the children's nutrition sector, marking a breakthrough in its dual strategy for infant and children's adult nutrition [3] - Mead Johnson has a decade-long research history in the field of milk fat globule membrane (MFGM) and holds 158 patents, establishing itself as a leader in this area [3] - The two major scientific validations this year further solidify Mead Johnson's industry-leading position and demonstrate its comprehensive and continuous approach to lifecycle nutrition [3]

Core Insights - The article emphasizes the importance of understanding consumer needs to achieve "real growth" in the infant and maternal industry, as discussed by the CEO of Mead Johnson China, Xiao Jingjing, at the Fortune Global 500 Summit [1][3]. Group 1: Industry Challenges and Opportunities - The global economy is facing multiple transformative forces, including the rise of artificial intelligence and an aging population, which pose challenges such as fluctuating birth rates and rational consumer behavior in the maternal and infant industry [3]. - Mead Johnson's philosophy is centered around providing the best start for babies, aligning with mothers' enduring wishes, and driving product innovation through scientific evidence [3][4]. Group 2: Scientific Research and Product Innovation - Mead Johnson has a long history of scientific research, having accumulated over 1,080 global patents and more than 100 scientific research outcomes, which have been cited over 9,200 times in the industry [4]. - The company has pioneered the exploration of Milk Fat Globule Membrane (MFGM), a key component in breast milk, which contains over 1,000 nutrients and plays a significant role in infant immune development and cognitive growth [6]. - Recent studies published in top academic journals have confirmed the positive effects of MFGM on cognitive development in infants, demonstrating its importance in enhancing brain structure and function [7]. Group 3: Product Development and Market Strategy - Mead Johnson has developed a comprehensive nutritional solution for all life stages, addressing market challenges posed by demographic changes, with products targeting both infants and older adults [8]. - The company has strengthened its brand trust through various initiatives, including collaborations with health associations and engaging in educational outreach to alleviate parenting anxiety [10].

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a key standard for assessing the quality of children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][4]. Group 1: Industry Developments - The CBME International Pregnancy, Baby, and Child Exhibition in Shanghai showcased the German children's nutrition brand inne, which launched a comprehensive clinical validation system for children's nutrition [1][3]. - Inne is leading a revolution in the industry by transitioning from "experience-driven" to "scientific evidence" in children's nutrition, establishing a new benchmark for product efficacy verification [2][11]. - The academic conference highlighted the shift in the industry towards clinical evidence as the core principle for children's nutritional supplements, marking a new era in the sector [1][11]. Group 2: Clinical Research and Findings - Clinical research conducted by inne in collaboration with various prestigious medical institutions has demonstrated the effectiveness of their calcium products, particularly the patented ingredient Kidtal, in promoting children's growth and bone health [5][7]. - The research findings have been published in the top-tier nutrition journal "Nutrients," indicating international academic recognition of the scientific validity and effectiveness of inne's products [5][6]. - Experts at the conference emphasized the necessity of clinical validation as the "gold standard" for assessing the safety and efficacy of calcium supplements for children [4][7]. Group 3: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen its exploration of clinical validation, aiming to provide safer, more effective, and precise nutritional solutions for children's health [12]. - The establishment of the inne Institute of Nutrition and Health signifies a new phase in the company's efforts to integrate cutting-edge research into practical products for consumers [8][10].